Radiosynthesis of [tetrazoyl- 11 C]irbesartan, a non-peptidic angiotensin II antagonist

Author： Ponchant M.   Demphel S.   Hinnen F.   Crouzel C.  

Publisher： Elsevier

ISSN： 0223-5234

Source： European Journal of Medicinal Chemistry, Vol.32, Iss.9, 1997-09, pp. : 747-752

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Non-peptidic urotensin-II receptor modulators

By Jin Jian   Douglas Stephen A  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 4, 2006-04 ,pp. : 467-479

Informa Healthcare

Access to resources Recommend Favorite

The design of potent, non-peptidic inhibitors of hepatitis C protease

By Andrews D.M.   Chaignot H.M.   Coomber B.A.   Dowle M.D.   Lucy Hind S.   Johnson M.R.   Jones P.S.   Mills G.   Patikis A.   Pateman T.J.   Ed Robinson J.   Slater M.J.   Trivedi N.  

European Journal of Medicinal Chemistry, Vol. 38, Iss. 4, 2003-04 ,pp. : 339-343

Elsevier

Access to resources Recommend Favorite

Efficacy and Tolerability of Irbesartan, an Angiotensin II Receptor Antagonist, in Primary Hypertension: A Double-Blind, Placebo-Controlled, Dose-Titration Study

By Guthrie R.  

Clinical Drug Investigation, Vol. 15, Iss. 3, 1998-03 ,pp. : 217-227

Adis International

Access to resources Recommend Favorite

Non-peptidic chymase inhibitors

By Aoyama Yasunori  

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 9, 2001-09 ,pp. : 1423-1428

Informa Healthcare

Access to resources Recommend Favorite

Irbesartan, an angiotensin II receptor antagonist, with selective PPAR‐gamma‐modulating activity improves function and structure of chemotherapy‐damaged ovaries in rats

By  

Fundamental & Clinical Pharmacology, Vol. 29, Iss. 3, 2015-06 ,pp. : 286-298

John Wiley & Sons Inc

Access to resources Recommend Favorite